Sarasin Investment Management has created a benchmark in absence of a suitable index
Sarasin Investment Management has created a special composite benchmark for its HealthSar Sicav as no suitable conventional index exists. Puttner said the Sicav, details of which were exclusively revealed in Investment Week last month, would benchmark against a composite index comprising elements drawn from the MSCI World Pharmaceutical index, the MSCI World Healthcare and Equipment Services index and the MSCI Biotechnology index. 'Because of the unusual nature of the fund it was very difficult to accurately benchmark against a conventional index,' she said. 'The fund will be c...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes